EA202191683A1 - Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии - Google Patents

Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии

Info

Publication number
EA202191683A1
EA202191683A1 EA202191683A EA202191683A EA202191683A1 EA 202191683 A1 EA202191683 A1 EA 202191683A1 EA 202191683 A EA202191683 A EA 202191683A EA 202191683 A EA202191683 A EA 202191683A EA 202191683 A1 EA202191683 A1 EA 202191683A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
presbiopia
phenylbutyrate
product containing
Prior art date
Application number
EA202191683A
Other languages
English (en)
Inventor
Масатомо Като
Томоко Ода
Кенсукэ Нодзаки
Original Assignee
Сантен Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сантен Фармасьютикал Ко., Лтд. filed Critical Сантен Фармасьютикал Ко., Лтд.
Publication of EA202191683A1 publication Critical patent/EA202191683A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к средству для лечения или профилактики глазных заболеваний, таких как пресбиопия, содержащему, в качестве активного ингредиента, 4-фенилмасляную кислоту или ее сложный эфир, или их фармацевтически приемлемые соли.
EA202191683A 2018-12-18 2019-12-17 Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии EA202191683A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018236724 2018-12-18
PCT/JP2019/049354 WO2020129965A1 (ja) 2018-12-18 2019-12-17 ４－フェニル酪酸を含有する老視の治療または予防剤

Publications (1)

Publication Number Publication Date
EA202191683A1 true EA202191683A1 (ru) 2021-09-01

Family

ID=71101922

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191683A EA202191683A1 (ru) 2018-12-18 2019-12-17 Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии

Country Status (9)

Country Link
US (1) US20220062209A1 (ru)
EP (1) EP3900714A4 (ru)
JP (1) JP7474706B2 (ru)
KR (1) KR20210104743A (ru)
CN (1) CN113164421A (ru)
AU (1) AU2019405587A1 (ru)
CA (1) CA3123378A1 (ru)
EA (1) EA202191683A1 (ru)
WO (1) WO2020129965A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023182480A1 (ja) * 2022-03-25 2023-09-28 株式会社坪田ラボ 水性組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370237A2 (en) * 2001-01-19 2003-12-17 Newlens, LLC Presbyopia treatment by lens alteration
CN1753683B (zh) * 2002-12-20 2010-05-26 视可舒研究公司 预防和治疗不良眼部病症的眼用制剂
DK2442647T3 (en) 2009-06-15 2016-05-30 Encore Health Llc Dithiolforbindelser, derivatives thereof, and the uses of these
US8962686B2 (en) 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
TN2010000251A1 (fr) * 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
WO2013149091A1 (en) * 2012-03-29 2013-10-03 The Regents Of The University Of Colorado, A Body Corporate Composition and method for treating neurodegenerative disease
US9872865B2 (en) * 2013-03-24 2018-01-23 Amylyx Pharmaceuticals Inc. Compositions for improving cell viability and methods of use thereof
WO2018030389A1 (ja) * 2016-08-08 2018-02-15 学校法人 慶應義塾 Ｎａｄ関連代謝産物の利用
WO2018164113A1 (ja) 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
CN108904696A (zh) * 2018-08-10 2018-11-30 广州佰集堂中医药研究中心 一种千里光护眼液及其制备工艺

Also Published As

Publication number Publication date
JPWO2020129965A1 (ja) 2021-11-04
AU2019405587A1 (en) 2021-07-01
KR20210104743A (ko) 2021-08-25
EP3900714A1 (en) 2021-10-27
EP3900714A4 (en) 2022-09-21
US20220062209A1 (en) 2022-03-03
CN113164421A (zh) 2021-07-23
JP7474706B2 (ja) 2024-04-25
CA3123378A1 (en) 2020-06-25
WO2020129965A1 (ja) 2020-06-25

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
PH12018500212A1 (en) 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
PH12016501357B1 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
PH12020550341A1 (en) Niraparib formulations
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
EA201890767A1 (ru) C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений
EA201891267A1 (ru) Фармацевтическая композиция, содержащая действенный ингибитор urat1
CR20200291A (es) Composiciones y métodos para el tratamiento de enfermedades metabólicas
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
EA201890906A1 (ru) ПРОИЗВОДНЫЕ ХИНОКСАЛИНА И ПИРИДОПИРАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
UY38345A (es) Composición farmacéutica que comprende agente antiplaquetario e inhibidor de la secreción de ácido g
TN2018000214A1 (en) Alkyl dihydroquinoline sulfonamide compounds
JP2017014155A5 (ru)
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
MY194044A (en) Lipoic acid choline ester compositions and methods to stabilize into pharmaceutically relevant drug products
PH12017501668A1 (en) Bace1 inhibitors
BR112018004249A2 (pt) composto, e, composição para prevenção ou tratamento de doenças trombóticas.
JOP20180071B1 (ar) استخدام مشتقات أمينو ألكيل بنزوثيازبين
EA201991817A1 (ru) Интраназальная композиция, включающая бетагистин
EA201800565A1 (ru) Композиция для лечения заболеваний уха, содержащая (+)-азасетрон
PH12020551620A1 (en) Compositions for preventing or treating dry eye
EA202191378A1 (ru) Активные сложноэфирные производные тестостерона, их композиции и применения